{
    "nct_id": "NCT03887715",
    "official_title": "A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression",
    "inclusion_criteria": "The patient must be in a major depressive disorder (MDD) episode for ≥ two years or have had at least four episodes of MDD, including the current episode.\n\nThe patient's depressive illness meets a minimum criterion of four prior failed treatments of adequate dose and duration as measured by a tool designed for this purpose.\n\nThe patient is experiencing a major depressive episode (MDE) as measured by a guideline recommended depression scale assessment tool on two visits, within a 45-day span prior to implantation of the VNS device.\n\nPatients must maintain a stable medication regimen for at least four weeks before device implantation.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "Current or lifetime history of psychotic features in any MDE;\n\nCurrent or lifetime history of schizophrenia or schizoaffective disorder;\n\nCurrent or lifetime history of any other psychotic disorder;\n\nCurrent or lifetime history of rapid cycling bipolar disorder;\n\nCurrent secondary diagnosis of delirium, dementia, amnesia, or other cognitive disorder;\n\nCurrent suicidal intent; or\n\nTreatment with another investigational device or investigational drugs.",
    "miscellaneous_criteria": ""
}